Washington, D.C. – Not even two weeks after the U.S. Drug and Food Administration (FDA) issued warning letters to five companies for mislabeling BMPEA (R-beta-methylphenethylamine) as a dietary ingredient; some members of the Senate are calling for the source of the BMPEA, Acacia rigidula, to be looked into by the Federal Trade Commission.
Silver Spring, MD – As of Thursday, April 23, five dietary supplement companies received warning letters for their use of an unapproved stimulant in their products. The companies were accused of using BMPEA (R-beta-methylphenethylamine) as a dietary supplement ingredient. The U.S. Food and Drug Administration (FDA) has given the firms 15 business days to make the needed adjustments to the eight total products involved.
Private label products are not an area retailers tend to dabble in lightly. Store brand dietary supplements are often an integral part of the business, and not just a sort of bonus option for customers that can be tacked on to the vitamin department without any planning or forethought. Innovative approaches to private label and a winning strategy are key to the overall health of many stores.